Drug News: October 2010Dexilant: new PPI, lansoprazole enantiomer; Prolia: twice-yearly SC injection for osteoporosis; Thalidomide approved for multiple myeloma. Keep it safe: improving patient safetyCommunity pharmacist development and implementation of strategies to improve patient safety. First intranasal flu vaccine AstraZeneca's FluMist offers patients an injection-free alternative to the traditional intramuscular flu vaccines. Practice Issues: Adverse reactions - TMP-SMX interaction with ACEIs and ARBs Study measures risk of hyperkalemia after TMP-SMX was prescribed for older patients on either an ACEI or an ARB. Pharmacists thrive in co-located environment Strong leadership key to successful integration into family health teams. Men and Women's Health 2010: Hypertension 2010 CHEP recommendations for pharmacists. Canadians realize depression is serious Go local for health IT: CMA In a major policy initiative, Canadian Medical Association releases annual report cards on EMR adoption progress First oral MS drug approved in U.S. Fingolimod (Gilenya, Novartis) offers patients an alternative to injectable therapies. Video: U of T nursing prof to lead home care safety study Dr. Diane Doran awarded $1 million to head research team First Previous 1979 1980 1981
